Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBay Pharmaceuticals (NBY) Non-cash Items (2016)

NovaBay Pharmaceuticals (NBY) has disclosed Non-cash Items for 6 consecutive years, with $1.7 million as the latest value for Q3 2016.

  • On a quarterly basis, Non-cash Items rose 21375.0% to $1.7 million in Q3 2016 year-over-year; TTM through Sep 2016 was $1.7 million, a 21375.0% increase, with the full-year FY2015 number at $19000.0, down 17.39% from a year prior.
  • Non-cash Items was $1.7 million for Q3 2016 at NovaBay Pharmaceuticals, up from $84000.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $5.0 million in Q4 2013 to a low of $8000.0 in Q3 2015.
  • A 5-year average of $1.7 million and a median of $555500.0 in 2013 define the central range for Non-cash Items.
  • Peak YoY movement for Non-cash Items: plummeted 99.54% in 2014, then skyrocketed 21375.0% in 2016.
  • NovaBay Pharmaceuticals' Non-cash Items stood at $4.5 million in 2012, then increased by 10.94% to $5.0 million in 2013, then tumbled by 99.54% to $23000.0 in 2014, then decreased by 17.39% to $19000.0 in 2015, then surged by 8942.11% to $1.7 million in 2016.
  • Per Business Quant, the three most recent readings for NBY's Non-cash Items are $1.7 million (Q3 2016), $84000.0 (Q2 2016), and $31000.0 (Q1 2016).